Ocugen's stock jumps 4% after saying FDA lifted hold on trial for experimental COVID-19 shot

Shares of Ocugen Inc. OCGN, -2.40% gained 4.7% in premarket trading on Friday after the company said the Food and Drug Administration lifted the clinical hold for the COVID-19 vaccine it’s developing with Bharat Biotech, a privately held biotech based in Hyderabad. The vaccine candidate is currently in a Phase 2/3 clinical trial, and Ocugen said it expects to start “this immuno-bridging and broadening clinical trial as soon as possible.” Ocugen’s stock has tumbled 61.8% over the past year, while the broader S&P 500 SPX, +1.50% is up 9.2%.

Source: Marketwatch

EUR is rising for the second day. Overview for 24.04.2024

The primary currency pair maintains its upward trajectory on Wednesday. The current EURUSD exchange rate stands at 1.0707. The currency market is witnessing increasing risk

Murrey Math Lines 24.04.2024 (USDJPY, USDCAD)

USDJPY, “US Dollar vs Japanese Yen” USDJPY quotes and the RSI remain in the overbought areas on D1. In this situation, the price is expected

Technical Analysis & Forecast 24.04.2024

EURUSD, “Euro vs US Dollar” The EURUSD pair escaped the consolidation range upwards and completed a growth link at 1.0710. Today it might drop to

Searching for the right forex broker is no easy task, but have no fear! Brokerswatch.com has made it very simple. Find the right brokers based on the criteria most important to you and compare them side by side for easier selection

Brokers By Regulator

Forex Brokers List

Trading Tools

Risk Warning: FX trading is high risk and may not be suitable for all investors. Leverage will create additional risks and loss. Before trading, please carefully consider your investment goals, experience and risk tolerance levels. Loss of part or all of your initial investment is possible; therefore do not invest money that you cannot afford to lose. It is advised to educate yourself about FX trading before you trade real money. Disclaimer: All data and information on this Website are provided “as is” and to be used only for information purposes. Information is not intended for trading or trading recommendations. The operators of this website shall not be liable for any loss incurred by you as a result of reliance on the information contained in the Website.